Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Silo Pharma, Inc. | Financial_Report.xls |
| EX-31.1 - RULE 13A-14(A)/15D14(A) CERTIFICATIONS OF MELVIN SCHLOSSBERG, THE PRINCIPAL EXECUTIVE OFFICER - Silo Pharma, Inc. | f10q0912ex31i_goldswap.htm |
| EX-32.2 - SECTION 1350 CERTIFICATIONS OF DONALD PTALIS, THE PRINCIPAL FINANCIAL OFFICER - Silo Pharma, Inc. | f10q0912ex32ii_goldswap.htm |
| EX-31.2 - RULE 13A-14(A)/15D14(A) CERTIFICATIONS OF DONALD PTALIS, THE PRINCIPAL FINANCIAL OFFICER - Silo Pharma, Inc. | f10q0912ex31ii_goldswap.htm |
| 10-Q - QUARTERLY REPORT - Silo Pharma, Inc. | f10q0912_goldswap.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Melvin Schlossberg, the President, Chief Executive Officer, Chairman and Director of Gold Swap Inc. (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 13, 2012
|
By:
|
/s/ Melvin Schlossberg | ||
| Name: | Melvin Schlossberg | ||
| Title: |
President, Chief Executive Officer, Secretary and
Director (Principal Executive Officer)
|
||
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.